Dr. Bharat B. Mittal

Claim this profile

Northwestern University

Studies Squamous Cell Carcinoma
Studies Oropharyngeal Carcinoma
3 reported clinical trials
10 drugs studied

Area of expertise

1

Squamous Cell Carcinoma

Bharat B. Mittal has run 2 trials for Squamous Cell Carcinoma. Some of their research focus areas include:

p16 negative
EGFR positive
EGFR negative
2

Oropharyngeal Carcinoma

Bharat B. Mittal has run 2 trials for Oropharyngeal Carcinoma. Some of their research focus areas include:

p16 negative
EGFR positive
EGFR negative

Affiliated Hospitals

Image of trial facility.

Northwestern University

Clinical Trials Bharat B. Mittal is currently running

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.

Recruiting

1 award

Phase 2 & 3

21 criteria

More about Bharat B. Mittal

Clinical Trial Related

12 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Bharat B. Mittal has experience with

  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • Fluorouracil
  • Gemcitabine Hydrochloride
  • Paclitaxel
  • Image Guided Radiation Therapy

Breakdown of trials Bharat B. Mittal has run

Squamous Cell Carcinoma

Oropharyngeal Carcinoma

Throat Cancer

Nasopharyngeal Carcinoma

Epstein-Barr Virus Infection

Other Doctors you might be interested in

Seema Jayachandran, PhD

Northwestern University

Srinadh Komanduri, MD, MS

Northwestern Memorial Hospital

Al B. Benson

Northwestern University

Frequently asked questions

Do I need insurance to participate in a trial?

What does Bharat B. Mittal specialize in?

Is Bharat B. Mittal currently recruiting for clinical trials?

Are there any treatments that Bharat B. Mittal has studied deeply?

What is the best way to schedule an appointment with Bharat B. Mittal?

What is the office address of Bharat B. Mittal?

Is there any support for travel costs?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security